Oleclumab (MEDI9447) EGFRm NSCLC Novel Combination Study - Wikidata - wikimedia - TriplyDB

Oleclumab (MEDI9447) EGFRm NSCLC Novel Combination Study

Oleclumab (MEDI9447) EGFRm NSCLC Novel Combination Study

http://www.wikidata.org/entity/Q64122519

about

Oleclumab (MEDI9447) EGFRm NSCLC Novel Combination Study

http://www.wikidata.org/entity/Q64122519

description

clinical trial

@en

klinisch onderzoek

@nl

name

Oleclumab (MEDI9447) EGFRm NSCLC Novel Combination Study

@en

type

label

Oleclumab (MEDI9447) EGFRm NSCLC Novel Combination Study

@en

prefLabel

Oleclumab (MEDI9447) EGFRm NSCLC Novel Combination Study

@en

P1132

Q64122519-9083BC1A-AB1F-49E7-A419-5696D72D966E

P1476

Q64122519-F3636B08-372A-4AE6-BBB7-0961549193B9

P17

Q64122519-11C7EB95-803C-4F29-933B-29755717205A

Q64122519-DD200927-5872-411A-8BAD-965D6AABE55B

P2899

Q64122519-155B195F-F218-4C73-B195-3CE1CFCDB185

P3098

Q64122519-AB24BAE5-ECD4-4D69-B3E9-DDA2C26F4F4A

P31

Q64122519-0A3D43C3-4221-4E6E-81D2-DB34701B6F8F

P4135

Q64122519-9A9F5774-94A5-45BF-BF5D-8C3FA7029614

P4844

Q64122519-F37B8A17-BC4F-4B7F-947A-611C84D2A97B

P580

Q64122519-49FF5BBB-D453-44F2-8372-BA231A1F1664

P582

Q64122519-40676ADA-56D9-4937-806F-4380AB798983

P6099

Q64122519-8E7886F7-CDD8-40C4-82FF-2D79A4CA9908

Q64122519-EB415708-A7BD-430A-92D2-F645762B02B7

P1132

98

http://www.w3.org/2001/XMLSchema#decimal

P1476

A Multiarm, Open-label, Multic ...... y Treated Advanced EGFRm NSCLC

@en

P17

Ameeriga Ütisriigiq

P2899

18

http://www.w3.org/2001/XMLSchema#decimal

P3098

NCT03381274

http://www.w3.org/2001/XMLSchema#string

P31

P4135

130

http://www.w3.org/2001/XMLSchema#decimal

P4844

P580

2018-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P582

2022-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6099

phase I clinical trial

phase II clinical trial